This book provides for an extensive legal analysis of the international drug control system in light of the growing challenges and criticism that this system faces. In the current debate on global drug policy, the central pillars of the international drug control system – the UN Drug Conventions as well as its institutions – are portrayed as outdated, suppressive and seen as an obstacle to necessary changes. The book’s objective is to provide an in-depth and positivist insight into drug control’s present legal framework and thus provide for a better understanding of the normative assumptions upon which drug control is currently based. This is attained by clarifying the objectives of the international drug control system and the premises by which these objectives are to be achieved. The objective of the current global framework of international drug control is the limitation of drugs to medical and scientific purposes. The meaning of this objective and its concrete implications for States’ parties as well as its problems from the perspective of other regimes of international law, most notably international human rights law, are extensively analysed. Additionally, the book focuses on how the international drug control system attempts to reach the objective of confining drugs to medical and scientific purposes, i.e. by setting up a universal system that exercises a rigid control on drug supply. The consequences of this heavy focus on the reduction of drug supply are outlined, and the book concludes by making suggestions on how the international drug control system could be reformed in the near future in order to better meet the existing challenges. The analysis occurs from a general international law perspective. It aims to map the international drug control system within a wider context of international law and to understand whether the problems that the international drug control system faces are exemplary for the difficulties that institutionalized systems of global scope face in the twenty-first century.
When Lou Grant premiered in the fall of 1977, it quickly became a symbol of television drama at its best. During its five years on the air, Lou Grant earned critical acclaim as an entertaining yet thoughtful drama about important social and political issues, a rarity for episodic television in the late 1970s. Douglass K. Daniel reveals how the creators of Lou Grant investigated journalism in the post-Watergate era to present a modem-day portrayal of the profession. They based characters, dialogue, and plots on the experiences of dozens of professional journalists. By researching social problems, they developed relevant story lines that gave episodes unusual immediacy. The show won thirteen Emmy Awards, among them two for Best Drama, and a Peabody Award. Journalists hailed the series as television's most realistic newspaper drama. The book describes the bitter controversy that erupted in 1982 when lead actor Edward Asner came under fire for his political beliefs regarding American involvement in El Salvador. Amid calls for advertiser boycotts, right-wing charges that Asner had aided the enemy, and falling ratings, CBS canceled the series. Daniel's intensive retrospect includes interviews with actors, producers, writers, directors, network censors, and journalists. He summarizes all 114 episodes. discusses original character sketches, and includes editorial cartoons.
Examines the impact that guerrilla warfare had on the Civil War, discussing how Confederate guerrillas' increasing use of plunder and violence led to a decline of support for them among Southerners and was a factor in the final defeat of the South.
Science news is met by the public with a mixture of fascination and disengagement. On the one hand, Americans are inflamed by topics ranging from the question of whether or not Pluto is a planet to the ethics of stem-cell research. But the complexity of scientific research can also be confusing and overwhelming, causing many to divert their attentions elsewhere and leave science to the "experts." Whether they follow science news closely or not, Americans take for granted that discoveries in the sciences are occurring constantly. Few, however, stop to consider how these advances--and the debates they sometimes lead to--contribute to the changing definition of the term "science" itself. Going beyond the issue-centered debates, Daniel Patrick Thurs examines what these controversies say about how we understand science now and in the future. Drawing on his analysis of magazines, newspapers, journals and other forms of public discourse, Thurs describes how science--originally used as a synonym for general knowledge--became a term to distinguish particular subjects as elite forms of study accessible only to the highly educated.
From Marilyn to Mussolini, people captivate people. A&E's Biography, best-selling autobiographies, and biographical novels testify to the popularity of the genre. But where does one begin? Collected here are descriptions and evaluations of over 10,000 biographical works, including books of fact and fiction, biographies for young readers, and documentaries and movies, all based on the lives of over 500 historical figures from scientists and writers, to political and military leaders, to artists and musicians. Each entry includes a brief profile, autobiographical and primary sources, and recommended works. Short reviews describe the pertinent biographical works and offer insight into the qualities and special features of each title, helping readers to find the best biographical material available on hundreds of fascinating individuals.
This book provides for an extensive legal analysis of the international drug control system in light of the growing challenges and criticism that this system faces. In the current debate on global drug policy, the central pillars of the international drug control system – the UN Drug Conventions as well as its institutions – are portrayed as outdated, suppressive and seen as an obstacle to necessary changes. The book’s objective is to provide an in-depth and positivist insight into drug control’s present legal framework and thus provide for a better understanding of the normative assumptions upon which drug control is currently based. This is attained by clarifying the objectives of the international drug control system and the premises by which these objectives are to be achieved. The objective of the current global framework of international drug control is the limitation of drugs to medical and scientific purposes. The meaning of this objective and its concrete implications for States’ parties as well as its problems from the perspective of other regimes of international law, most notably international human rights law, are extensively analysed. Additionally, the book focuses on how the international drug control system attempts to reach the objective of confining drugs to medical and scientific purposes, i.e. by setting up a universal system that exercises a rigid control on drug supply. The consequences of this heavy focus on the reduction of drug supply are outlined, and the book concludes by making suggestions on how the international drug control system could be reformed in the near future in order to better meet the existing challenges. The analysis occurs from a general international law perspective. It aims to map the international drug control system within a wider context of international law and to understand whether the problems that the international drug control system faces are exemplary for the difficulties that institutionalized systems of global scope face in the twenty-first century.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.